Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bleeding with menopausal hormone therapy: physiological or pathological?

Martha Hickey1

  • 1School of Women's and Infants' Health, King Edward Memorial Hospital, University of Western Australia. mhickey@meddent.uwa.edu.au <mhickey@meddent.uwa.edu.au>

Menopause International
|December 20, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Online Menopause Information-Seeking Search Patterns and Commercial Content Over 2 Decades.

JAMA network open·2026
Same author

Managing menopause after cancer: a qualitative analysis of healthcare professionals' perspectives.

Journal of cancer survivorship : research and practice·2026
Same author

Reconsidering menopausal hormone therapy in women over 65: aligning practice with evolving evidence.

Menopause (New York, N.Y.)·2026
Same author

Trends in Government-Subsidised Menopausal Hormone Therapy Dispensing in Australia Between 2014 and 2023.

The Australian & New Zealand journal of obstetrics & gynaecology·2026
Same author

Risk factors, management and consequences of severe menopausal vasomotor symptoms.

Nature reviews. Endocrinology·2026
Same author

Correlation of BMI With Potential Barriers to Mammographic Screening: Body Image, Pain, and Perceived Risk of Breast Cancer-A Cross-Sectional Study.

Journal of medical imaging and radiation oncology·2026
Same journal

Estrogen and the brain: does estrogen treatment improve cognitive function?

Menopause international·2016
Same journal

Vitamin D supplements for the prevention of osteoporosis judged 'inappropriate'.

Menopause international·2014
Same journal

Estradiol associated with lower thrombotic risk than conjugated equine estrogens when used as oral HRT.

Menopause international·2014
Same journal

Should HRT be duration limited?

Menopause international·2013
Same journal

Stand by your man: the importance of the female in male sexual problems.

Menopause international·2013
Same journal

The effect of hormones on the lower urinary tract.

Menopause international·2013
See all related articles

Abnormal bleeding during hormone replacement therapy (HRT) is common. Research is needed to understand its mechanisms and guide clinical management for persistent cases.

Area of Science:

  • Gynecology
  • Reproductive Endocrinology

Background:

  • Abnormal bleeding is a frequent cause for discontinuing hormone replacement therapy (HRT).
  • Clinical guidelines lack consensus on investigating and managing persistent abnormal bleeding during HRT.
  • Understanding the underlying mechanisms is crucial for effective patient care.

Purpose of the Study:

  • To review current understanding of abnormal bleeding during HRT.
  • To discuss diagnostic modalities for abnormal bleeding.
  • To explore potential mechanisms driving endometrial bleeding.

Main Methods:

  • Review of literature on abnormal bleeding in HRT.
  • Discussion of diagnostic tools: transvaginal ultrasound, endometrial biopsy, hysteroscopy.
  • Exploration of proposed molecular mechanisms of endometrial vascular breakdown.

Related Experiment Videos

Main Results:

  • Mechanisms of abnormal endometrial bleeding are poorly understood.
  • Bleeding does not consistently correlate with endometrial histology or HRT type/dose.
  • Potential mechanisms involve angiogenic factors, matrix metalloproteinases, hemostasis, and leukocytes.

Conclusions:

  • Endometrial bleeding involves vascular breakdown, likely locally regulated.
  • Further research into molecular mechanisms is needed to improve HRT management.
  • Standardized investigation and management protocols for HRT-associated bleeding are warranted.